Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0UF8M
|
|||
| Drug Name |
IMO-9200
|
|||
| Indication | Autoimmune disease [ICD-11: 4A40-4A45; ICD-9: 279] | Phase 1 | [1] | |
| Company |
Idera Pharmaceuticals Cambridge, MA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Toll-like receptor (TLR) | Target Info | Antagonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.